l ages, but it most often starts in childhood. In the U.S., more than 22 million people are known to have asthma, including more than 6 million children. Each year in the U.S., asthma causes approximately 500,000 hospitalizations, 134 million days of restricted activity and 5,000 deaths. It is estimated that 80 to 90 percent of all individuals who have asthma will experience symptoms of EIB with vigorous exercise or activity.
About ProAir® HFA (albuterol sulfate) Inhalation Aerosol
ProAir® HFA (albuterol sulfate) Inhalation Aerosol is indicated in patients 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.
Important Safety Information
If your symptoms become significantly worse when you use ProAir® HFA, contact your doctor immediately. This may indicate either a worsening of your asthma or a reaction to the medication, which may rarely occur with the first use of a new canister of ProAir® HFA. Either of these could be life-threatening.
What to tell your doctor before using ProAir® HFA: If you have a heart, blood, or seizure disorder, high blood pressure, diabetes, or an overactive thyroid, be sure to tell your doctor. Also make sure your doctor knows all the medications you are taking -- especially heart medications and drugs that treat depression -- because some medications may interfere with how well your asthma medications work. Do not exceed the recommended dose.
Side effects associated with ProAir® HFA (albuterol sulfate) Inhalation Aerosol included headache, rapid heartbeat, pain, dizziness, and irritation of the throat and nose.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Please see full prescribing inform
Page: 1 2 3 4 5 6 7 Related medicine technology :1
|SOURCE Teva Respiratory LLC, a subsidiary of Teva Pharmaceutical Industries Ltd.|
Copyright©2010 PR Newswire.
All rights reserved
. PolyGel® Receives SADMERC Approval for L-Code L3670 for ThermoActive™ Cold & Hot Mobile Compression Shoulder Orthosis2
. PolyGel® Receives SADMERC Approval for L-Code L0627 for New ThermoActive™ Plus Cold & Hot Compression Lumbar Orthosis3
. State Launches Immunize for Good Marketing Campaign to Remind Parents Immunizations are Safe and the Best Way to Prevent Childhood Illness4
. Oklahoma City Thunder Point Guard Russell Westbrook and NBA Legend Bob Lanier Join Vaccines for Teens Educational Campaign to Urge Local Teens to Take Their Best Shot at Health5
. Medela Announces Virtual Human Milk Collection Campaign Award Recipients in Honor of 2010 Prematurity Awareness Month6
. PCMA: Independent Drugstore Lobby Continues Disclosure Double Standard Transparency Campaign7
. Lilly Surpasses United Way 2010 Campaign Goal8
. 7,000 Bracelets For Hope™ - A Rare Disease Awareness Campaign9
. RxDrugSAFE™ Featured in National Campaign by Purdue Pharma and NCPA10
. Pfizer Offers First 500,000 Consumers Free Advil® to Launch Medicine Cabinet Cleanout Campaign11
. In Honor of American Pharmacists Month, Sams Club® Pharmacies Host October Awareness Campaign Including Free Medication Check-Ups